SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
-7.27%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$391M
AUM Growth
+$391M
(+21%)
Cap. Flow
+$88.5M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
99.75%
Holding
13
New
4
Increased
4
Reduced
–
Closed
2
Top Buys
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$62.8M |
| 2 |
AGN
Allergan plc
AGN
|
$42.1M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$24.7M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$10.6M |
| 5 |
Biogen
BIIB
|
$9.56M |
Top Sells
| 1 |
ADXS
Advaxis, Inc.
ADXS
|
$1.42M |
Sector Composition
| 1 | Healthcare | 86.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $132M | 33.75% | 413,858 +30,000 | +8% | +$9.56M |
|
|
BIVV
2
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $62.8M | 16.08% | +1,165,000 | New | +$62.8M |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $52.5M | 13.45% | 1,922,000 +170,000 | +10% | +$4.65M |
|
4
Innoviva
INVA
$1.29B
| $51.9M | 13.3% | 3,660,705 +60,000 | +2% | +$851K |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $42.1M | 10.77% | +257,300 | New | +$42.1M |
|
|
6
Ironwood Pharmaceuticals
IRWD
$214M
| $24.7M | 6.33% | +1,650,000 | New | +$24.7M |
|
|
ICPT
7
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $10.6M | 2.73% | +182,300 | New | +$10.6M |
|
|
ACHN
8
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $7.2M | 1.84% | 2,500,000 +363,200 | +17% | +$1.05M |
|
|
NVLN
9
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $3.2M | 0.82% | 1,025,000 | – | – |
|
|
SEEL
10
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $2.66M | 0.68% | 1,447,906 | – | – |
|
11
AbbVie
ABBV
$372B
| $967K | 0.25% | 10,000 | – | – |
|
|
ADXS
12
DELISTED
Advaxis, Inc.
ADXS
| – | – | -339,180 | Closed | -$1.42M |
|